CIPLA | PROCTER & GAMBLE HEALTH | CIPLA/ PROCTER & GAMBLE HEALTH |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 32.3 | 34.4 | 93.8% | View Chart |
P/BV | x | 5.2 | 10.5 | 49.3% | View Chart |
Dividend Yield | % | 0.6 | 2.0 | 28.1% |
CIPLA PROCTER & GAMBLE HEALTH |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
CIPLA Mar-23 |
PROCTER & GAMBLE HEALTH Jun-23 |
CIPLA/ PROCTER & GAMBLE HEALTH |
5-Yr Chart Click to enlarge
|
||
High | Rs | 1,185 | 5,366 | 22.1% | |
Low | Rs | 852 | 3,883 | 21.9% | |
Sales per share (Unadj.) | Rs | 281.9 | 740.7 | 38.1% | |
Earnings per share (Unadj.) | Rs | 35.1 | 138.2 | 25.4% | |
Cash flow per share (Unadj.) | Rs | 49.7 | 155.2 | 32.0% | |
Dividends per share (Unadj.) | Rs | 8.50 | 95.00 | 8.9% | |
Avg Dividend yield | % | 0.8 | 2.1 | 40.6% | |
Book value per share (Unadj.) | Rs | 289.2 | 447.6 | 64.6% | |
Shares outstanding (eoy) | m | 807.15 | 16.60 | 4,862.3% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 3.6 | 6.2 | 57.9% | |
Avg P/E ratio | x | 29.0 | 33.5 | 86.7% | |
P/CF ratio (eoy) | x | 20.5 | 29.8 | 68.8% | |
Price / Book Value ratio | x | 3.5 | 10.3 | 34.1% | |
Dividend payout | % | 24.2 | 68.7 | 35.2% | |
Avg Mkt Cap | Rs m | 822,164 | 76,761 | 1,071.1% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 38,301 | 2,062 | 1,857.7% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 227,531 | 12,296 | 1,850.4% | |
Other income | Rs m | 5,121 | 184 | 2,784.8% | |
Total revenues | Rs m | 232,653 | 12,480 | 1,864.2% | |
Gross profit | Rs m | 48,079 | 3,247 | 1,480.8% | |
Depreciation | Rs m | 11,721 | 281 | 4,171.2% | |
Interest | Rs m | 1,095 | 8 | 14,226.0% | |
Profit before tax | Rs m | 40,384 | 3,142 | 1,285.3% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 12,029 | 847 | 1,419.6% | |
Profit after tax | Rs m | 28,355 | 2,295 | 1,235.7% | |
Gross profit margin | % | 21.1 | 26.4 | 80.0% | |
Effective tax rate | % | 29.8 | 27.0 | 110.5% | |
Net profit margin | % | 12.5 | 18.7 | 66.8% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 168,051 | 11,713 | 1,434.8% | |
Current liabilities | Rs m | 50,333 | 6,791 | 741.2% | |
Net working cap to sales | % | 51.7 | 40.0 | 129.3% | |
Current ratio | x | 3.3 | 1.7 | 193.6% | |
Inventory Days | Days | 73 | 263 | 27.9% | |
Debtors Days | Days | 7 | 343 | 1.9% | |
Net fixed assets | Rs m | 117,318 | 10,617 | 1,105.0% | |
Share capital | Rs m | 1,614 | 166 | 972.5% | |
"Free" reserves | Rs m | 231,845 | 7,265 | 3,191.5% | |
Net worth | Rs m | 233,460 | 7,431 | 3,141.9% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 290,067 | 22,330 | 1,299.0% | |
Interest coverage | x | 37.9 | 409.1 | 9.3% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 0.8 | 0.6 | 142.4% | |
Return on assets | % | 10.2 | 10.3 | 98.5% | |
Return on equity | % | 12.1 | 30.9 | 39.3% | |
Return on capital | % | 17.8 | 42.4 | 41.9% | |
Exports to sales | % | 22.6 | 0 | - | |
Imports to sales | % | 8.9 | 13.1 | 68.0% | |
Exports (fob) | Rs m | 51,516 | NA | - | |
Imports (cif) | Rs m | 20,202 | 1,605 | 1,258.4% | |
Fx inflow | Rs m | 64,282 | 1,465 | 4,387.2% | |
Fx outflow | Rs m | 20,202 | 1,605 | 1,258.4% | |
Net fx | Rs m | 44,080 | -140 | -31,440.7% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 32,377 | 2,360 | 1,371.9% | |
From Investments | Rs m | -23,885 | -215 | 11,109.3% | |
From Financial Activity | Rs m | -9,583 | -985 | 973.2% | |
Net Cashflow | Rs m | -968 | 1,160 | -83.4% |
Indian Promoters | % | 13.4 | 0.0 | - | |
Foreign collaborators | % | 20.0 | 51.8 | 38.7% | |
Indian inst/Mut Fund | % | 50.0 | 20.3 | 246.7% | |
FIIs | % | 25.7 | 7.6 | 338.6% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 66.5 | 48.2 | 138.1% | |
Shareholders | 425,731 | 56,730 | 750.5% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare CIPLA With: SUN PHARMA DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES MANKIND PHARMA
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Cipla | Procter & Gamble Health | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 2.14% | -0.69% | 1.18% |
1-Month | 1.44% | -7.59% | -0.75% |
1-Year | 68.35% | -3.15% | 61.82% |
3-Year CAGR | 22.61% | -9.16% | 18.16% |
5-Year CAGR | 23.28% | 5.72% | 19.79% |
* Compound Annual Growth Rate
Here are more details on the Cipla share price and the Procter & Gamble Health share price.
Moving on to shareholding structures...
The promoters of Cipla hold a 33.5% stake in the company. In case of Procter & Gamble Health the stake stands at 51.8%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Cipla and the shareholding pattern of Procter & Gamble Health.
Finally, a word on dividends...
In the most recent financial year, Cipla paid a dividend of Rs 8.5 per share. This amounted to a Dividend Payout ratio of 24.2%.
Procter & Gamble Health paid Rs 95.0, and its dividend payout ratio stood at 68.7%.
You may visit here to review the dividend history of Cipla, and the dividend history of Procter & Gamble Health.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.